Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ACTRN12626000162314) titled 'Comparative Efficacy of Budesonide and Fexofenadine in Seasonal Allergic Rhinitis: A randomized clinical trial' on Feb. 9.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Primary Sponsor: Damascus University
Condition:
Allergic Rhinitis
Allergic Rhinitis
Inflammatory and Immune System - Allergies
Intervention:
Two intervention groups were studied. One group received fexofenadine only, and the other group received budesonide only. Fexofenadine was administered orally as a tablet once daily at a dose of 120 mg for participants younger than 18 years and 1...